Quick Look at Illumina (ILMN)

Illumina logged a -5.0% change during today's afternoon session, and is now trading at a price of $95.12 per share. On average, analysts give it a target price of $135.78.

Illumina, Inc. develops, manufactures, and markets life science tools and integrated systems for large-scale analysis of genetic variation and function. The large-cap company is based in the United States.

What to Consider if You Are Thinking of Buying Illumina:

  • Illumina has moved -58.0% over the last year.

  • ILMN has a forward P/E ratio of 99.1 based on its EPS guidance of 0.96.

  • Over the last 5 years, earnings per share (EPS) have been growing at a compounded average rate of -14.6%.

  • The company has a price to earnings growth (PEG) ratio of -23.46.

  • Its Price to Book (P/B) ratio is 2.55

Illumina Has None

Date Reported Cash Flow from Operations ($ k) Capital expenditures ($ k) Free Cash Flow ($ k) YoY Growth (%)
2023 392,000 286,000 106,000 -68.55
2022 545,000 208,000 337,000 -62.18
2021 1,080,000 189,000 891,000 5.82
2020 1,051,000 209,000 842,000 0.0
2019 1,051,000 209,000 842,000 -0.47
2018 1,142,000 296,000 846,000


The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.